1-4 of 4
Authors: Viknesh Selvarajah
Journal Article
#2267 IL-33 Inhibition with tozorakimab for diabetic kidney disease: a randomized, placebo-controlled phase 2b study Free
Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024, gfae069-0716-2267, https://doi.org/10.1093/ndt/gfae069.716
Published: 23 May 2024
Journal Article
#3000 EFFICACY AND SAFETY OF COTADUTIDE, A DUAL GLP1-GLUCAGON RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND T2DM Free
Nephrology Dialysis Transplantation, Volume 38, Issue Supplement_1, June 2023, gfad063a_3000, https://doi.org/10.1093/ndt/gfad063a_3000
Published: 14 June 2023
Journal Article
#2695 THE ENVIRONMENTAL IMPACT OF CHRONIC KIDNEY DISEASE INTERNATIONALLY: RESULTS OF A LIFE CYCLE ASSESSMENT Free
Nephrology Dialysis Transplantation, Volume 38, Issue Supplement_1, June 2023, gfad063c_2695, https://doi.org/10.1093/ndt/gfad063c_2695
Published: 14 June 2023
Journal Article
#5413 FRONTIER-1: A PHASE 2B STUDY OF IL-33 BLOCKADE IN DIABETIC KIDNEY DISEASE Free
Nephrology Dialysis Transplantation, Volume 38, Issue Supplement_1, June 2023, gfad063c_5413, https://doi.org/10.1093/ndt/gfad063c_5413
Published: 14 June 2023
